VALIDATION OF MR TECH OF THERAPEUTIC EFFICACY FOR DRUG DISCOV IN ALZH DISEASE

MR 技术对 ALZH 疾病药物发现治疗效果的验证

• 批准号: 8170472
• 负责人: MICHAEL GARWOOD
• 金额: $ 2.57万
• 依托单位: UNIVERSITY OF MINNESOTA
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-06-01 至 2011-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8170472
• 关键词: Alzheimer' s Disease; Area; Computer Retrieval of Information on Scientific Projects Database; Detection; Disease; Evaluation; Funding; Grant; Institution; Mus; Nerve Degeneration; Pharmaceutical Preparations; Physiologic pulse; Research; Research Personnel; Resources; Senile Plaques; Source; Techniques; Treatment Efficacy; United States National Institutes of Health; Validation; Work

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Alzheimer's work has focused on two major areas: evaluation of pulse sequences for best detection of amyloid plaques and evaluation of different MR techniques to detect neurodegeneration in genetically modified mice.

该子项目是利用该技术的众多研究子项目之一 资源由 NIH/NCRR 资助的中心拨款提供。子项目及 研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金， 因此可以在其他 CRISP 条目中表示。列出的机构是 中心，不一定是研究者的机构。 阿尔茨海默病的工作主要集中在两个主要领域：评估脉冲序列以最好地检测淀粉样斑块，以及评估不同的磁共振技术以检测转基因小鼠的神经退行性变。